Characterization of interference with 6 commercial delta9-tetrahydrocannabinol immunoassays by efavirenz (glucuronide) in urine.
Rossi
Steven
S
Yaksh
Tony
T
Bentley
Heather
H
van den Brande
Geoffrey
G
Grant
Igor
I
Ellis
Ronald
R
D000480:Alkynes; D019380:Anti-HIV Agents / Q000652:urine*; D048588:Benzoxazines; D003429:Cross Reactions; D003521:Cyclopropanes; D013759:Dronabinol / Q000652:urine*; D005189:False Positive Reactions; D020719:Glucuronides / Q000652:urine*; D006213:Hallucinogens / Q000652:urine*; D006801:Humans; D007118:Immunoassay; D010078:Oxazines / Q000652:urine*; D015813:Substance Abuse Detection / Q000379:methods*
D000480:Alkynes; D019380:Anti-HIV Agents; D048588:Benzoxazines; D003521:Cyclopropanes; D020719:Glucuronides; D006213:Hallucinogens; D010078:Oxazines; D013759:Dronabinol; C098320:efavirenz